| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |